BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16311409)

  • 41. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.
    Zhang X; Sun H; Danila DC; Johnson SR; Zhou Y; Swearingen B; Klibanski A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1262-7. PubMed ID: 11889197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary neoplasia.
    Melmed S
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):81-92. PubMed ID: 7913031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mechanisms of pituitary tumorigenesis].
    Acunzo J; Saveanu A; Gérard C; Enjalbert A; Barlier A
    Presse Med; 2009 Jan; 38(1):76-83. PubMed ID: 18938057
    [No Abstract]   [Full Text] [Related]  

  • 45. PTTG and Ki-67 expression in pituitary adenomas.
    Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
    Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
    Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
    Abbass SA; Asa SL; Ezzat S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y; Tang D; Deng J; Su C
    Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pathophysiology of pituitary adenomas.
    Dworakowska D; Grossman AB
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):525-41. PubMed ID: 19945021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Etiopathogenesis of pituitary tumors].
    Morange-Ramos I; Pellegrini I; Caccavelli L; Brue T; Enjalbert A; Jaquet P
    Ann Endocrinol (Paris); 1994; 55(1):25-32. PubMed ID: 7802423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
    Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in pathogenesis of pituitary adenomas.
    Yong Y; Cong-xin D; Ren-zhi W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):127-31. PubMed ID: 21529438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular basis of pituitary oncogenesis.
    Tada M; Kobayashi H; Moriuchi T
    J Neurooncol; 1999; 45(1):83-96. PubMed ID: 10728913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The genetics of pituitary adenomas.
    Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. cAMP pathway and pituitary tumorigenesis.
    Lania A; Mantovani G; Spada A
    Ann Endocrinol (Paris); 2012 Apr; 73(2):73-5. PubMed ID: 22525824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
    Zhan X; Desiderio DM
    Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
    Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
    Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The molecular biology of pituitary tumors: a personal perspective.
    Grossman AB
    Pituitary; 2009; 12(3):265-70. PubMed ID: 19058014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.
    Tebani A; Jotanovic J; Hekmati N; Sivertsson Å; Gudjonsson O; Edén Engström B; Wikström J; Uhlèn M; Casar-Borota O; Pontén F
    Acta Neuropathol Commun; 2021 Nov; 9(1):181. PubMed ID: 34758873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PTTG--a new pituitary tumour transforming gene.
    McCabe CJ; Gittoes NJ
    J Endocrinol; 1999 Aug; 162(2):163-6. PubMed ID: 10425453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.